BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 26362541)

  • 1. Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.
    Lamoureux EL; Mcintosh R; Constantinou M; Fenwick EK; Xie J; Casson R; Finkelstein E; Goldberg I; Healey P; Thomas R; Ang GS; Pesudovs K; Crowston J
    Trials; 2015 Sep; 16():406. PubMed ID: 26362541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Buszewicz M;
    Lancet; 2019 Apr; 393(10180):1505-1516. PubMed ID: 30862377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial.
    Vickerstaff V; Ambler G; Bunce C; Xing W; Gazzard G;
    Trials; 2015 Nov; 16():517. PubMed ID: 26559142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial.
    Ang GS; Fenwick EK; Constantinou M; Gan ATL; Man REK; Casson RJ; Finkelstein EA; Goldberg I; Healey PR; Pesudovs K; Sanmugasundram S; Xie J; McIntosh R; Jackson J; Wells AP; White A; Martin K; Walland MJ; Crowston JG; Lamoureux EL
    Br J Ophthalmol; 2020 Jun; 104(6):813-821. PubMed ID: 31488427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Barton K; Wormald R; Morris S; Hunter R; Rubin G; Buszewicz M; Ambler G; Bunce C;
    Br J Ophthalmol; 2018 May; 102(5):593-598. PubMed ID: 28903966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
    Best UP; Domack H; Schmidt V
    Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients.
    De Keyser M; De Belder M; De Belder J; De Groot V
    Acta Ophthalmol; 2018 Aug; 96(5):e577-e581. PubMed ID: 28636188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand.
    Ngan K; Fraser E; Buller S; Buller A
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2181-2189. PubMed ID: 30132278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics.
    Konstantakopoulou E; Gazzard G; Vickerstaff V; Jiang Y; Nathwani N; Hunter R; Ambler G; Bunce C;
    Br J Ophthalmol; 2018 May; 102(5):599-603. PubMed ID: 28982956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Worldwide Price Comparison of Glaucoma Medications, Laser Trabeculoplasty, and Trabeculectomy Surgery.
    Zhao PY; Rahmathullah R; Stagg BC; Almobarak F; Edward DP; Robin AL; Stein JD
    JAMA Ophthalmol; 2018 Nov; 136(11):1271-1279. PubMed ID: 30178000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Adeleke M; Vickerstaff V; Ambler G; Hunter R; Bunce C; Nathwani N; Barton K;
    Ophthalmology; 2023 Feb; 130(2):139-151. PubMed ID: 36122660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser trabeculoplasty for open angle glaucoma.
    Rolim de Moura C; Paranhos A; Wormald R
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003919. PubMed ID: 17943806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma.
    McIlraith I; Strasfeld M; Colev G; Hutnik CM
    J Glaucoma; 2006 Apr; 15(2):124-30. PubMed ID: 16633226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty.
    Woo DM; Healey PR; Graham SL; Goldberg I
    Clin Exp Ophthalmol; 2015; 43(4):320-7. PubMed ID: 25287743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of selective laser trabeculoplasty vs topical medications for glaucoma.
    Seider MI; Keenan JD; Han Y
    Arch Ophthalmol; 2012 Apr; 130(4):529-30. PubMed ID: 22491929
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.
    King AJ; Fernie G; Azuara-Blanco A; Burr JM; Garway-Heath T; Sparrow JM; Vale L; Hudson J; MacLennan G; McDonald A; Barton K; Norrie J
    Br J Ophthalmol; 2018 Jul; 102(7):922-928. PubMed ID: 29074496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argon laser trabeculoplasty and reduction of ocular hypotensive medication used by glaucoma patients.
    Vaidergorn PG; Susanna R
    Can J Ophthalmol; 2006 Feb; 41(1):44-50. PubMed ID: 16462872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of anti-inflammatory therapy on intraocular pressure reduction following selective laser trabeculoplasty.
    Realini T; Charlton J; Hettlinger M
    Ophthalmic Surg Lasers Imaging; 2010; 41(1):100-3. PubMed ID: 20128578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma.
    Berdahl JP; Khatana AK; Katz LJ; Herndon L; Layton AJ; Yu TM; Bauer MJ; Cantor LB
    J Med Econ; 2017 Jul; 20(7):760-766. PubMed ID: 28471282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.